San Diego-based mostly Viking Therapeutics marked alone as a serious competitor from the weight loss drug current market in February just after revealing promising details from a mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when presented to be a weekly injection As well as in Marc